A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer

Abstract Abnormal expression of the potassium channel tetramerization domain containing 12 (KCTD12) is closely related to the occurrence and development of various tumors, but a pan-cancer analysis of KCTD12 has not yet been conducted. We explored the association between KCTD12 and more than 30 huma...

Full description

Bibliographic Details
Main Authors: Pan Liu, Zhilan Liu, Qiankun Luo, Qiang Fu, Xu Zhang, Pengfei Yu, Shuai Zhou, Yingying Wang, Jiali Zhang, Song Chen, Hongwei Zhang, Qinghai Zhu, Tao Qin
Format: Article
Language:English
Published: Nature Portfolio 2023-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-41091-8
_version_ 1797559850921623552
author Pan Liu
Zhilan Liu
Qiankun Luo
Qiang Fu
Xu Zhang
Pengfei Yu
Shuai Zhou
Yingying Wang
Jiali Zhang
Song Chen
Hongwei Zhang
Qinghai Zhu
Tao Qin
author_facet Pan Liu
Zhilan Liu
Qiankun Luo
Qiang Fu
Xu Zhang
Pengfei Yu
Shuai Zhou
Yingying Wang
Jiali Zhang
Song Chen
Hongwei Zhang
Qinghai Zhu
Tao Qin
author_sort Pan Liu
collection DOAJ
description Abstract Abnormal expression of the potassium channel tetramerization domain containing 12 (KCTD12) is closely related to the occurrence and development of various tumors, but a pan-cancer analysis of KCTD12 has not yet been conducted. We explored the association between KCTD12 and more than 30 human malignancies using The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. First, the mRNA and protein levels of KCTD12 were examined and their correlations with tumor stage and survival were explored. Second, we analyzed the infiltration of CD8+ and CD4+ T cells and cancer-associated fibroblasts in tumors and explored the correlation between KCTD12 expression and tumor cell stemness, genomic heterogeneity, and diagnostic specificity. Finally, we explored the molecular mechanisms associated with KCTD12 using KEGG/GO analysis. The results showed that KCTD12 mRNA and protein expression levels decreased in most tumors was significantly associated with the prognosis of tumor patients, and the phosphorylation level of KCTD12 decreased in several tumors, such as S200 and T196, pancreatic adenocarcinoma (PAAD), lung adenocarcinoma (LUAD), and breast invasive cancer (BRCA). The expression of KCTD12 was positively correlated with the degree of cancer-associated fibroblasts infiltration in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), head and neck squamous cell carcinoma (HNSC), PAAD, and stomach adenocarcinoma (STAD). The relationship between KCTD12 expression and CD8+ and CD4+ T cell infiltration was also clarified. KCTD12 showed high diagnostic sensitivity for various types of tumors and may be involved in tumor cell biology by affecting tumor cell stemness, tumor burden, and other characteristics. Finally, we analyzed the molecular functions of KCTD12 and possible KEGG/GO signaling pathways. In this study, we developed a biological marker for diagnosis, prognosis, and immune infiltration of the pan-cancers.
first_indexed 2024-03-10T17:52:05Z
format Article
id doaj.art-ad7f707a1e4a4818a6dbe8fe7966cd08
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-10T17:52:05Z
publishDate 2023-08-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-ad7f707a1e4a4818a6dbe8fe7966cd082023-11-20T09:20:37ZengNature PortfolioScientific Reports2045-23222023-08-0113111510.1038/s41598-023-41091-8A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancerPan Liu0Zhilan Liu1Qiankun Luo2Qiang Fu3Xu Zhang4Pengfei Yu5Shuai Zhou6Yingying Wang7Jiali Zhang8Song Chen9Hongwei Zhang10Qinghai Zhu11Tao Qin12Department of Hepato-Biliary-Pancreatic Surgery, Zhengzhou University People’s Hospital (Henan Provincial People’s Hospital)Henan University of Chinese MedicineDepartment of Hepato-Biliary-Pancreatic Surgery, Zhengzhou University People’s Hospital (Henan Provincial People’s Hospital)Department of Hepato-Biliary-Pancreatic Surgery, Zhengzhou University People’s Hospital (Henan Provincial People’s Hospital)Department of Hepato-Biliary-Pancreatic Surgery, Zhengzhou University People’s Hospital (Henan Provincial People’s Hospital)Department of Hepato-Biliary-Pancreatic Surgery, Zhengzhou University People’s Hospital (Henan Provincial People’s Hospital)Translational Research Institute, Zhengzhou University People’s HospitalAcademy of Medical Sciences, Zhengzhou UniversityAcademy of Medical Sciences, Zhengzhou UniversityTranslational Research Institute, Zhengzhou University People’s HospitalDepartment of Hepato-Biliary-Pancreatic Surgery, Zhengzhou University People’s Hospital (Henan Provincial People’s Hospital)Zhumadian Central HospitalDepartment of Hepato-Biliary-Pancreatic Surgery, Zhengzhou University People’s Hospital (Henan Provincial People’s Hospital)Abstract Abnormal expression of the potassium channel tetramerization domain containing 12 (KCTD12) is closely related to the occurrence and development of various tumors, but a pan-cancer analysis of KCTD12 has not yet been conducted. We explored the association between KCTD12 and more than 30 human malignancies using The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. First, the mRNA and protein levels of KCTD12 were examined and their correlations with tumor stage and survival were explored. Second, we analyzed the infiltration of CD8+ and CD4+ T cells and cancer-associated fibroblasts in tumors and explored the correlation between KCTD12 expression and tumor cell stemness, genomic heterogeneity, and diagnostic specificity. Finally, we explored the molecular mechanisms associated with KCTD12 using KEGG/GO analysis. The results showed that KCTD12 mRNA and protein expression levels decreased in most tumors was significantly associated with the prognosis of tumor patients, and the phosphorylation level of KCTD12 decreased in several tumors, such as S200 and T196, pancreatic adenocarcinoma (PAAD), lung adenocarcinoma (LUAD), and breast invasive cancer (BRCA). The expression of KCTD12 was positively correlated with the degree of cancer-associated fibroblasts infiltration in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), head and neck squamous cell carcinoma (HNSC), PAAD, and stomach adenocarcinoma (STAD). The relationship between KCTD12 expression and CD8+ and CD4+ T cell infiltration was also clarified. KCTD12 showed high diagnostic sensitivity for various types of tumors and may be involved in tumor cell biology by affecting tumor cell stemness, tumor burden, and other characteristics. Finally, we analyzed the molecular functions of KCTD12 and possible KEGG/GO signaling pathways. In this study, we developed a biological marker for diagnosis, prognosis, and immune infiltration of the pan-cancers.https://doi.org/10.1038/s41598-023-41091-8
spellingShingle Pan Liu
Zhilan Liu
Qiankun Luo
Qiang Fu
Xu Zhang
Pengfei Yu
Shuai Zhou
Yingying Wang
Jiali Zhang
Song Chen
Hongwei Zhang
Qinghai Zhu
Tao Qin
A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer
Scientific Reports
title A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer
title_full A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer
title_fullStr A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer
title_full_unstemmed A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer
title_short A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer
title_sort pan cancer analysis of potassium channel tetramerization domain containing 12 in human cancer
url https://doi.org/10.1038/s41598-023-41091-8
work_keys_str_mv AT panliu apancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT zhilanliu apancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT qiankunluo apancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT qiangfu apancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT xuzhang apancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT pengfeiyu apancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT shuaizhou apancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT yingyingwang apancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT jializhang apancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT songchen apancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT hongweizhang apancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT qinghaizhu apancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT taoqin apancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT panliu pancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT zhilanliu pancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT qiankunluo pancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT qiangfu pancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT xuzhang pancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT pengfeiyu pancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT shuaizhou pancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT yingyingwang pancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT jializhang pancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT songchen pancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT hongweizhang pancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT qinghaizhu pancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer
AT taoqin pancanceranalysisofpotassiumchanneltetramerizationdomaincontaining12inhumancancer